Effect of endothelin on bladder contraction: Potential role in bladder hyperactivity

Pharmacology

Volumn 69, Issue 1, 2003, Pages 7-11

  Westfall, Timothy D ^a   McCafferty, Gerald P ^a   Pullen, Mark ^a   Ventre, Jessica ^a   Eybye, Marianne ^a   Jugus, Malcolm J ^a   Brooks, Stuart A ^a   Hieble, J Paul ^a   Brooks, David P ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Endothelin; ETA; ETB; SB 217242; SB 247083; Urinary bladder

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENRASENTAN; SARAFOTOXIN S6C; SB 247083;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; HYPERACTIVITY; HYPERTENSION; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; URINE VOLUME;

ANIMALS; BENZOFURANS; CARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; HYPERTENSION; INDANS; INFUSIONS, INTRAVENOUS; MALE; MUSCLE CONTRACTION; PROPIONIC ACIDS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; URINARY BLADDER; URINATION; URINATION DISORDERS;

EID: 0043175426     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071243     Document Type: Article

References (13)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Borges R, Grafenstein HV, Knight DE: Tissue selectivity of endothelin. Eur J Pharmacol 1989;165:223-230.
3. Maggi CA, Giuliani S, Patacchini R, Santicioli P, Turini D, Barbanti G, Meli A: Potent contractile activity of endothelin on the human isolated urinary bladder. Br J Pharmacol 1989;96:755-757.
4. Garcia-Pascual A, Larsson B, Andersson KE: Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. Acta Physiol Scand 1990;140:545-555.
5. Persson K, Garcia-Pascual A, Holmquist F, Andersson KE: Endothelin-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: Calcium dependence and phosphoinositide hydrolysis. Gen Pharmacol 1992;23:445-453.
6. A receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder. Br J Pharmacol 1994;111:473-479.
7. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of cDNA encoding an endothelin receptor. Nature 1990;348:730-732.
8. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
9. Elshourbagy N, Korman DR, Wu HL, Sylvester DR, Lee JA, Nuthalaganti P, Bergsma DJ, Kumar CS, Nambi P: Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993;268:3873-3879.
10. Douglas SA, Ohlstein EH: Signal transduction mechanisms mediating the vascular actions of endothelin. J Vasc Res 1997;34:152-164.
11. Saenz de Tejada IS, Mueller JD, de Las Morenas A, Machado M, Moreland RB, Krane RJ, Wolfe HJ, Traish AM: Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, smooth muscle and fibroblasts suggests autocrine and paracrine cellular regulation. J Urol 1992;148:1290-1298.
12. Ohlstein EH, Nambi P, Lago A, Hay DW, Beck G, Fong KL, Eddy EP, Smith P, Ellens H, Elliott JD: Nonpeptide endothelin receptor antagonists. VI. Pharmacological characterization of SB 217242, a potent and highly bio-available endothelin receptor antagonist. J Pharmacol Exp Ther 1996;276:609-615.
13. Douglas SA, Nambi P, Gellai M, Luengo JI, Xiang JN, Brooks DP, Ruffolo RR Jr, Elliot JD, Ohlstein EH: Pharmacologic characterization of the novel, orally available endothelin-A-selective antagonist SB 247083. J Cardiovasc Pharmacol 1998;31(suppl 1):S273-S276.